Crispr Therapeutics shares owned by AQR Capital Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by AQR Capital Management
from 13F filings
Historical chart of AQR Capital Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by AQR Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.8M | 28k | 64.81 |
| 2025-06-30 | $1.1M | 22k | 48.64 |
| 2025-03-31 | $860k | 25k | 34.00 |
| 2022-06-30 | $517k | 8.5k | 60.79 |
| 2022-03-31 | $570k | 9.1k | 62.75 |
| 2021-12-31 | $513k | 6.8k | 75.74 |
| 2021-09-30 | $432k | 3.9k | 111.86 |
| 2021-06-30 | $356k | 2.2k | 161.74 |